Mitogen-activated protein kinase kinase kinase 3D structures
From Proteopedia
Jump to navigationJump to search
Mitogen-activated protein kinase kinase kinase
Updated on 31-December-2025
{"openlevels":0}
- MAP3K1; Domains – kinase 10-307; catalytic 325-619; SH3-binding 465-480; TOG 648-867
- 6nfy, 6nfz - hMAP3K1 kinase domain + cancer drug - human
- 6ng0 - hMAP3K1 kinase domain (mutant) + cancer drug
- 6nfz - hMAP3K1 kinase domain + inhibitor
- 8yp4 - hMAP3K1 kinase domain (mutant) + inhibitor
- 6nyb - hMAP3K1 kinase domain (mutant) + B-raf + 14-3-3 protein zeta – Cryo EM
- 6whb - hMAP3K1 TOG domain + cancer drug
- 1uti – MAP3K1 SH3-binding domain +GRB2-related adaptor protein 2 – mouse
- 6nfy, 6nfz - hMAP3K1 kinase domain + cancer drug - human
- MAP3K2
- MAP3K3
- MAP3K5 (Ask1; Apoptosis signal-regulating kinase 1)
- MAP3K7 or TAK1
- 2eva – hMAP3K7/MAP3K7-interacting protein 1
- 2y1y, 4gs4, 4l3p, 4l52, 4l53, 4o91, 5gjd, 5gjf, 5gjg, 5e7r, 5jga, 5jgb, 5jgd, 7nth - hMAP3K7/MAP3K7-interacting protein 1 + inhibitor
- 8gw3 - hMAP3K7/TGF-beta-activated kinase 1 and MAP3K7-interacting protein 1
- 9fpd - hMAP3K7/TGF-beta-activated kinase 1 and MAP3K7-interacting protein 1 + inhibitor
- MAP3K9
- 3dtc - hMAP3K9 (mutant) + inhibitor
- MAP3K10
- 2rf0 - hMAP3K10 SH3 domain – NMR
- MAP3K11
- 6cq7 - hMAP3K11 SH3 domain/huntington fusion peptide
- 6cq7 - hMAP3K11 SH3 domain/huntington fusion peptide
- MAP3K12 kinase domain 115-402; or DLK or dual leucine zipper bearing kinase
- MAP3K14 kinase domain 343-686 or NIK or NF-kappa-beta-inducing kinase
- MAP3K15
- 6v0m - hMAP3K15 residues 1241-1308
- 6v0m - hMAP3K15 residues 1241-1308
- MAP3K20
- 9rsx - hMAP3K20 + plasminogenactivator inhibitor + ribosomal protein S3 + receptor of activated protein C kinase – Cryo EM
- 9rsx - hMAP3K20 + plasminogenactivator inhibitor + ribosomal protein S3 + receptor of activated protein C kinase – Cryo EM
- MAP3K MLT or ZAK